🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

What shares were popular in the latest week? Rolls-Royce, AstraZeneca and more

Published 21/03/2021, 11:28
JPM
-
PFC
-
AZN
-
RR
-
BT
-
ICAG
-
AZN
-

Five of the most viewed stocks pages on uk.investing.com in the latest week.

Rolls-Royce

Rolls-Royce Holdings PLC (LON:RR) shares have been in focus after the company announced results in the previous week and as economies begin to reopen and air travel resumes. The company’s shares were also upgraded by JPMorgan (NYSE:JPM) during the week. Shares opened the week at 114.60, hit a high of 128.71 on Thursday before falling on Friday to close the week at 117.00. 

Rolls-Royce shares

Petrofac

Petrofac Ltd (LON:PFC) shares underperformed in the last week after long-term partner ADNOC suspended the UK-listed energy company from competing for new contracts in the UAE amid bribery allegations. Shares opened the week at 109.40, fell 19% on Monday, hit a low of 93.70 on Wednesday and closed the week at 95.46. 

Petrofac shares

International Consolidated Airlines

British Airways parent International Consolidated Airlines Group S.A. (LON:ICAG) had a mixed week as fears of a third Covid wave in Europe took hold that could disrupt summer travel plans. The EU announced plans for a vaccine pass that would allow residents to travel across the bloc but with the stuttering vaccine programme, the reality is that open borders could be a long way off. The company also announced plans to raise EUR 1bln through a bond issue and there were reports British Airways is considering selling its HQ amid the switch to homeworking. Shares opened the week at 214.40, hit a high of 222.10 on Tuesday and closed the week lower at 206.70.

IAG shares

AstraZeneca (NASDAQ:AZN)

AstraZeneca PLC (LON:AZN) shares were in focus after the whirlwind week for its vaccine in Europe. At the beginning of the week, a number of European countries began suspending their vaccine amid reports of blood clots. On Tuesday, the European Medicines Agency announced they were investigating the issue and by Thursday ruled that the vaccine was safe and effective, adding that the benefits outweigh the risks. Shares opened the week 6,951, hit a high on Wednesday of 7,232 and closed the week at 7,110.

AstraZeneca shares

BT Group

Telecoms names, particularly BT Group PLC (LON:BT), were in focus after the UK 5G spectrum auction. There had been some expectation that telecoms companies would pay as much as £2.5bln for the spectrum but the auction raised just £1.36bln. BT spent about £450mln for the 5G infrastructure. BT shares opened the week at 138.55, hit a high of 155.35 on Friday before closing lower at 145.35.

BT shares

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.